Genetic and structural validation of Aspergillus fumigatus N-acetylphosphoglucosamine mutase as an antifungal target. Issue 5 (4th September 2013)

• Record Type: Journal Article
• Authors: Fang, Wenxia; Du, Ting; Raimi, Olawale G.; Hurtado-Guerrero, Ramón; Mariño, Karina; Ibrahim, Adel F. M.; Albarbarawi, Osama; Ferguson, Michael A. J.; Jin, Cheng; Van Aalten, Daan M. F.
• Is Part Of: Bioscience reports. Volume 33:Issue 5(2013)
• Publication Date: 2013-09-04
• Subjects: cell wall -- drug target -- enzyme -- inhibitor -- nucleotide sugar -- protein structure; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20130053
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract : Aspergillus fumigatus is the causative agent of IA (invasive aspergillosis) in immunocompromised patients. It possesses a cell wall composed of chitin, glucan and galactomannan, polymeric carbohydrates synthesized by processive glycosyltransferases from intracellular sugar nucleotide donors. Here we demonstrate that A. fumigatus possesses an active Af AGM1 ( A. fumigatus N -acetylphosphoglucosamine mutase), a key enzyme in the biosynthesis of UDP (uridine diphosphate)–GlcNAc ( N- acetylglucosamine), the nucleotide sugar donor for chitin synthesis. A conditional agm1 mutant revealed the gene to be essential. Reduced expression of agm1 resulted in retarded cell growth and altered cell wall ultrastructure and composition. The crystal structure of Af AGM1 revealed an amino acid change in the active site compared with the human enzyme, which could be exploitable in the design of selective inhibitors. Af AGM1 inhibitors were discovered by high-throughput screening, inhibiting the enzyme with IC50 s in the low μM range. Together, these data provide a platform for the future development of Af AGM1 inhibitors with antifungal activity.